Last edition
News about "chronic lymphocytic leukaemia"
US FDA Approves Dr Reddy's Rituximab Biosimilar for the US Market
Dr Reddy's Laboratories has secured US FDA approval for its rituximab biosimilar, expanding its global biosimilars portfolio and strengthening its presence in the US biologics market.
Chronic Lymphocytic Leukaemia | 03/08/2026 | By News Bureau
FDA clears 14-month, chemotherapy-free combination for first-line treatment of chronic lymphocytic leukaemia and small lymphocytic lymphoma, backed by positive Phase III AMPLIFY trial data.
Chronic Lymphocytic Leukaemia | 23/02/2026 | By News Bureau | 257
Kernal Biologics receives USD 48 Million from ARPA-H
The funding received by Kernal Biologics from ARPA-H is to develop lower cost in vivo CAR T-cell therapies for hematological cancers.
Chronic Lymphocytic Leukaemia | 09/10/2025 | By Dineshwori | 238
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy